Headline
- Aigen Investment Management Boosts Holdings in Danaher
- Hedge Funds Increase Positions in Danaher
- Analyst Ratings Reflect Positive Outlook for Danaher
Aigen Investment Management LP recently acquired a new position in Danaher Co. (NYSE:DHR) during the third quarter, according to filings with the Securities and Exchange Commission (SEC). This addition includes over 10,000 shares of the conglomerate's stock, making it one of Aigen's notable holdings. Danaher represents approximately 0.6% of Aigen's investment portfolio, positioning it as the firm's 20th largest holding.
Other institutional investors and hedge funds have also made strategic moves involving Danaher recently. For instance, nVerses Capital LLC and CarsonAllaria Wealth Management Ltd. each opened new positions in the company during the second quarter, while MFA Wealth Advisors LLC and Financial Connections Group Inc. similarly acquired new stakes. Western Pacific Wealth Management LP also increased its stake earlier this year. Overall, 79.05% of Danaher’s ownership is attributed to hedge funds and institutional investors, underscoring the interest from professional financial managers in the company's growth.
Analysts Issue New Ratings on Danaher
Analyst ratings for Danaher have recently been updated. Barclays adjusted their outlook on Danaher shares, setting a price target of $275.00, maintaining a balanced stance on the company. Meanwhile, Stifel Nicolaus raised their target for Danaher to $265.00, expressing a neutral view. Bank of America also lifted its price objective to $275.00, adding to the confidence in the stock’s stability. KeyCorp analysts took a more optimistic stance, raising the target price to $310.00.
Wells Fargo & Company initiated coverage on Danaher, setting an initial target of $280.00, further adding to the positive outlook from financial institutions. Analysts’ ratings reflect a blend of stable and favorable views, with five analysts marking it with a hold rating and fifteen issuing a positive outlook on the company. This results in a consensus rating of “Moderate Buy” and a calculated average price target of approximately $287.